-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2
المؤلفون: Jesús F. San-Miguel, U. Mey, Mario Boccadoro, Thierry Facon, Roman Hájek, P. Moreau, M.V. Mateos, E. Terpos, M.A. Dimopoulos, Michele Cavo, Fredrik Schjesvold, H. Goldschmidt, Gordon Cook, Michel Delforge, Sonja Zweegman, H. Einsele, Pieter Sonneveld
المساهمون: Hematology, CCA - Cancer Treatment and quality of life, Dimopoulos M.A., Moreau P., Terpos E., Mateos M.V., Zweegman S., Cook G., Delforge M., Hajek R., Schjesvold F., Cavo M., Goldschmidt H., Facon T., Einsele H., Boccadoro M., San-Miguel J., Sonneveld P., Mey U.
المصدر: EHA Guidelines Committee & ESMO Guidelines Committee 2021, ' Multiple myeloma : EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up † ', Annals of Oncology, vol. 32, no. 3, pp. 309-322 . https://doi.org/10.1016/j.annonc.2020.11.014
Annals of Oncology, 32(3), 309-322. Oxford University Press
Annals of Oncology, 32(3), 309-322. Elsevier Ltd.
Dimopoulos, M A, Moreau, P, Terpos, E, Mateos, M V, Zweegman, S, Cook, G, Delforge, M, Hájek, R, Schjesvold, F, Cavo, M, Goldschmidt, H, Facon, T, Einsele, H, Boccadoro, M, San-Miguel, J, Sonneveld, P & Mey, U 2021, ' Multiple Myeloma : EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up ', HemaSphere . https://doi.org/10.1097/HS9.0000000000000528
HemaSphereمصطلحات موضوعية: Pediatrics, medicine.medical_specialty, MINIMAL RESIDUAL DISEASE, BORTEZOMIB, THERAPY, Follow-Up Studie, CONDITIONING REGIMEN, follow-up, ORAL IXAZOMIB, Medicine, Multiple myeloma, Societies, Medical, Science & Technology, treatment, INTERGROUPE FRANCOPHONE, business.industry, Follow up studies, STEM-CELL TRANSPLANTATION, Hematology, Guideline Article - Consensus based, medicine.disease, OPEN-LABEL, PHASE-III, Clinical Practice, multiple myeloma, diagnosi, Oncology, Diagnosis treatment, business, Life Sciences & Biomedicine, clinical practice guideline, prognosi, LENALIDOMIDE PLUS DEXAMETHASONE, Human
وصف الملف: application/pdf; Electronic-eCollection; STAMPA
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4
المؤلفون: Marie-Laure Risse, Adrian Alegre, David Simpson, Kazutaka Sunami, Marlène Inchauspé, Sosana Delimpasi, Simon J. Harrison, Ming Chung Wang, Aurore Perrot, Cyrille Hulin, Frank Campana, Andrew Spencer, Helgi van de Velde, Thierry Facon, Philip Vlummens, P. W. Richardson, Sandrine Macé, Kwee Yong
المصدر: British Journal of Haematology
BRITISH JOURNAL OF HAEMATOLOGYمصطلحات موضوعية: Male, Abnormal Karyotype, high‐, Trisomy, Kaplan-Meier Estimate, gain (1q21), Gastroenterology, Dexamethasone, cytogenetics, INTERNATIONAL STAGING SYSTEM, MOLECULAR, 0302 clinical medicine, Antineoplastic Agents, Immunological, Recurrence, Medicine and Health Sciences, Multiple myeloma, risk, Randomized Controlled Trials as Topic, Aged, 80 and over, LENALIDOMIDE, INTERGROUPE FRANCOPHONE, refractory multiple myeloma, ABNORMALITIES, Bortezomib, POMALIDOMIDE, high‐risk, Hematology, Middle Aged, Thalidomide, Myeloma Proteins, Chromosomes, Human, Pair 1, 030220 oncology & carcinogenesis, Female, Multiple Myeloma, medicine.drug, Research Paper, isatuximab, EXPRESSION, Adult, Risk, medicine.medical_specialty, LOW-DOSE DEXAMETHASONE, BORTEZOMIB, Subgroup analysis, Antibodies, Monoclonal, Humanized, CLASSIFICATION, 03 medical and health sciences, Refractory, Internal medicine, relapsed/refractory multiple myeloma, medicine, Humans, Immunologic Factors, Adverse effect, Lenalidomide, Aged, Febrile Neutropenia, Salvage Therapy, business.industry, SAR650984, Pneumonia, Haematological malignancy ‐ Clinical, Pomalidomide, medicine.disease, Discontinuation, relapsed, Clinical Trials, Phase III as Topic, business, 030215 immunology
وصف الملف: application/pdf
-
5
المؤلفون: Marian Stevens-Kroef, M. van Marwijk Kooy, Henk M. Lokhorst, Hans-Walter Lindemann, Anna Potamianou, Gerard M. J. Bos, B. van der Holt, Igor Wolfgang Blau, Annemiek Broijl, Christoph Scheid, Peter Brossart, Pieter Sonneveld, Sonja Zweegman, R. Schaafsma, Sandra Croockewit, Reinier Raymakers, Le Jarari, Ulrich Duehrsen, H Salwender, Jens Hillengass, Dirk Hose, Elias K. Mai, Anna Jauch, Marc-Steffen Raab, Michael Pfreundschuh, Thomas Hielscher, Paula F. Ypma, Marie-Jose Kersten, Katja Weisel, Edo Vellenga, H. Goldschmidt, Uta Bertsch
المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Stem Cell Aging Leukemia and Lymphoma (SALL), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), Hematology, CCA - Cancer immunology, CCA - Imaging, CCA - Biomarkers, CCA - Clinical Therapy Development, CCA - Evaluation of Cancer Care, CCA - Target Discovery & Preclinial Therapy Development, Anatomy and neurosciences, CCA - Cancer Treatment and Quality of Life, Clinical Haematology, AII - Amsterdam institute for Infection and Immunity, AII - Inflammatory diseases
المصدر: Leukemia, 32(2), 383-390. Nature Publishing Group
Leukemia, 32, 2, pp. 383-390
Goldschmidt, H, Lokhorst, H M, Mai, E K, van der Holt, B, Blau, I W, Zweegman, S, Weisel, K C, Vellenga, E, Pfreundschuh, M, Kersten, M J, Scheid, C, Croockewit, S, Raymakers, R, Hose, D, Potamianou, A, Jauch, A, Hillengass, J, Stevens-Kroef, M, Raab, M S, Broijl, A, Lindemann, H W, Bos, G M J, Brossart, P, van Marwijk Kooy, M, Ypma, P, Duehrsen, U, Schaafsma, R M, Bertsch, U, Hielscher, T, Jarari, L, Salwender, H J & Sonneveld, P 2018, ' Bortezomib before and after high-dose therapy in myeloma : long-term results from the phase III HOVON-65/GMMG-HD4 trial ', Leukemia, vol. 32, no. 2, pp. 383-390 . https://doi.org/10.1038/leu.2017.211
Leukemia, 32(2), 383. Nature Publishing Group
Leukemia, 32, 383-390مصطلحات موضوعية: Male, Melphalan, 2ND PRIMARY MALIGNANCIES, Cancer Research, DIAGNOSED MULTIPLE-MYELOMA, Medizin, PLUS DEXAMETHASONE, Bortezomib, 0302 clinical medicine, Autologous stem-cell transplantation, Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14], Multiple myeloma, INTERGROUPE FRANCOPHONE, Hazard ratio, Hematopoietic Stem Cell Transplantation, Hematology, Middle Aged, Prognosis, Progression-Free Survival, Thalidomide, Oncology, 030220 oncology & carcinogenesis, DEXAMETHASONE COMBINATION, DELETION 17P, Female, Multiple Myeloma, medicine.drug, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Adult, medicine.medical_specialty, Adolescent, Urology, MAINTENANCE TREATMENT, Transplantation, Autologous, Young Adult, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, medicine, Humans, Progression-free survival, Aged, Chromosome Aberrations, business.industry, STEM-CELL TRANSPLANTATION, STAGING SYSTEM, medicine.disease, RANDOMIZED-TRIAL, Surgery, Transplantation, business, Follow-Up Studies, 030215 immunology
وصف الملف: application/pdf; image/pdf
-
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
9
المؤلفون: Jo Caers, Laurent Garderet, K. Martin Kortüm, Michael E. O’Dwyer, Niels W.C.J. van de Donk, Mascha Binder, Sandra Maria Dold, Francesca Gay, Jill Corre, Yves Beguin, Heinz Ludwig, Alessandra Larocca, Christoph Driessen, Meletios A. Dimopoulos, Mario Boccadoro, Martin Gramatzki, Sonja Zweegman, Hermann Einsele, Michele Cavo, Hartmut Goldschmidt, Pieter Sonneveld, Michel Delforge, Holger W. Auner, Evangelos Terpos, Monika Engelhardt
المساهمون: Caers, Jo, Garderet, Laurent, Kortüm, K Martin, O'Dwyer, Michael E, van de Donk, Niels W C J, Binder, Mascha, Dold, Sandra Maria, Gay, Francesca, Corre, Jill, Beguin, Yve, Ludwig, Heinz, Larocca, Alessandra, Driessen, Christoph, Dimopoulos, Meletios A, Boccadoro, Mario, Gramatzki, Martin, Zweegman, Sonja, Einsele, Hermann, Cavo, Michele, Goldschmidt, Hartmut, Sonneveld, Pieter, Delforge, Michel, Auner, Holger W, Terpos, Evangelo, Engelhardt, Monika, CCA - Cancer Treatment and quality of life, Hematology
المصدر: Caers, J, Garderet, L, Kortüm, K M, O'Dwyer, M E, van de Donk, N W C J, Binder, M, Dold, S M, Gay, F, Corre, J, Beguin, Y, Ludwig, H, Larocca, A, Driessen, C, Dimopoulos, M A, Boccadoro, M, Gramatzki, M, Zweegman, S, Einsele, H, Cavo, M, Goldschmidt, H, Sonneveld, P, Delforge, M, Auner, H W, Terpos, E & Engelhardt, M 2018, ' European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when ', Haematologica, vol. 103, no. 11, pp. 1772-1784 . https://doi.org/10.3324/haematol.2018.189159
Haematologica, 103(11), 1772-1784. Ferrata Storti Foundation
Haematologicaمصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Monitoring, medicine.medical_treatment, FREE LIGHT-CHAIN, Immunology, MEDLINE, MINIMAL RESIDUAL DISEASE, CIRCULATING PLASMA-CELLS, Disease, 1102 Cardiovascular Medicine And Haematology, INTERNATIONAL STAGING SYSTEM, Guideline Article, Cytogenetics, 03 medical and health sciences, 0302 clinical medicine, POSITRON-EMISSION-TOMOGRAPHY, Internal medicine, Diagnosis, PROGNOSTIC-SIGNIFICANCE, medicine, Intensive care medicine, Multiple myeloma, GENE-EXPRESSION, Minimal Residual Disease, Hematology, Science & Technology, INTERGROUPE FRANCOPHONE, business.industry, medicine.disease, Minimal residual disease, 3. Good health, Clinical trial, Radiation therapy, multiple myeloma, HIGH-RISK, 030104 developmental biology, 030220 oncology & carcinogenesis, Radiological weapon, Practice Guidelines as Topic, DELETION 17P, business, Life Sciences & Biomedicine, Multiple Myeloma
وصف الملف: Print-Electronic; STAMPA
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d28a6598a4936df9990c152c790f075
https://lirias.kuleuven.be/handle/20.500.12942/693431 -
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.
Find this article in full text from Springer Verlag.